Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 3/20 | 0.37 |
| ▸ | PAM | P19021 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25218755 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL25211926 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL2119448 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL25196488 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL3052145 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL25198827 | 0.98 | NAAA (0.50) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL21383406 | 0.96 | NAAA (0.48) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL21749894 | 0.96 | NAAA (0.48) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL11196810 | 0.96 | NAAA (0.48) | NAAADNM1DGKAKDM5ALMNA | |
| SCHEMBL168800 | 0.96 | NAAA (0.48) | NAAADNM1DGKAKDM5ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | WHITELEY CORP PTY LTD (AU) | 2026-03-19 | — | — | US | claimed |
| US-12427215-B2 | Endoscope disinfectant | WHITELEY CORPORATION PTY LTD (AU) | 2025-09-30 | — | — | US | claimed |
| CN-118140923-A | Improved Endoscope Disinfectant | 怀特利集团控股有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-113645845-B | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2024-04-19 | — | — | CN | claimed |
| US-20220023475-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2022-01-27 | — | — | US | claimed |
| EP-3923721-A1 | IMPROVED ENDOSCOPE DISINFECTANT | Whiteley Corporation Pty Ltd (AU) | 2021-12-22 | — | — | EP | claimed |
| CN-113645845-A | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2021-11-12 | — | — | CN | claimed |
| WO-2020163900-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2020-08-20 | — | — | WO | claimed |
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | WHITELEY CORP PTY LTD (AU) | 2026-03-19 | — | — | US | disclosed |
| US-12427215-B2 | Endoscope disinfectant | WHITELEY CORPORATION PTY LTD (AU) | 2025-09-30 | — | — | US | disclosed |
| CN-118140923-A | Improved Endoscope Disinfectant | 怀特利集团控股有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113645845-B | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20220023475-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2022-01-27 | — | — | US | disclosed |
| EP-3923721-A1 | IMPROVED ENDOSCOPE DISINFECTANT | Whiteley Corporation Pty Ltd (AU) | 2021-12-22 | — | — | EP | disclosed |
| CN-113645845-A | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2021-11-12 | — | — | CN | disclosed |
| WO-2020163900-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2020-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | PMS2, GABBR1, GABRP | NAAA 1936/4885DNM1 1815/4885DGKA 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.